Koshkina NV - Search Results

1

Expression of granulocyte-colony-stimulating factor and its receptor in human Ewing sarcoma cells and patient tumor specimens: potential consequences of granulocyte-colony-stimulating factor administration.

Morales-Arias J, Meyers PA, Bolontrade MF, Rodriguez N, Zhou Z, Reddy K, Chou AJ, Koshkina NV, Kleinerman ES. Morales-Arias J, et al. Among authors: koshkina nv. Cancer. 2007 Oct 1;110(7):1568-77. doi: 10.1002/cncr.22964. Cancer. 2007. PMID: 17694551 Free article.

2

Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases.

Duan X, Jia SF, Koshkina N, Kleinerman ES. Duan X, et al. Cancer. 2006 Mar 15;106(6):1382-8. doi: 10.1002/cncr.21744. Cancer. 2006. PMID: 16453328 Free article.

3

Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.

Lafleur EA, Koshkina NV, Stewart J, Jia SF, Worth LL, Duan X, Kleinerman ES. Lafleur EA, et al. Among authors: koshkina nv. Clin Cancer Res. 2004 Dec 1;10(23):8114-9. doi: 10.1158/1078-0432.CCR-04-0353. Clin Cancer Res. 2004. PMID: 15585647

4

Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases.

Koshkina NV, Kleinerman ES. Koshkina NV, et al. Int J Cancer. 2005 Sep 1;116(3):458-63. doi: 10.1002/ijc.21011. Int J Cancer. 2005. PMID: 15800950

5

Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.

Zhou Z, Lafleur EA, Koshkina NV, Worth LL, Lester MS, Kleinerman ES. Zhou Z, et al. Among authors: koshkina nv. Mol Cancer Res. 2005 Dec;3(12):685-91. doi: 10.1158/1541-7786.MCR-05-0092. Mol Cancer Res. 2005. PMID: 16380506

6

Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.

Koshkina NV, Khanna C, Mendoza A, Guan H, DeLauter L, Kleinerman ES. Koshkina NV, et al. Mol Cancer Res. 2007 Oct;5(10):991-9. doi: 10.1158/1541-7786.MCR-07-0007. Mol Cancer Res. 2007. PMID: 17951400

7

Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.

Koshkina NV, Rao-Bindal K, Kleinerman ES. Koshkina NV, et al. Cancer. 2011 Aug 1;117(15):3457-67. doi: 10.1002/cncr.25884. Epub 2011 Feb 1. Cancer. 2011. PMID: 21287529 Free PMC article.

8

Inhibition of Cdc42-interacting protein 4 (CIP4) impairs osteosarcoma tumor progression.

Koshkina NV, Yang G, Kleinerman ES. Koshkina NV, et al. Curr Cancer Drug Targets. 2013 Jan;13(1):48-56. Curr Cancer Drug Targets. 2013. PMID: 22920438

9

The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.

Rao-Bindal K, Koshkina NV, Stewart J, Kleinerman ES. Rao-Bindal K, et al. Among authors: koshkina nv. Curr Cancer Drug Targets. 2013 May;13(4):411-22. doi: 10.2174/1568009611313040005. Curr Cancer Drug Targets. 2013. PMID: 23410027 Free PMC article.

10

Intranasal granulocyte-macrophage colony-stimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis.

Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES. Quezada G, et al. Among authors: koshkina nv. Antimicrob Agents Chemother. 2008 Feb;52(2):716-8. doi: 10.1128/AAC.00760-07. Epub 2007 Nov 5. Antimicrob Agents Chemother. 2008. PMID: 17984233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters